A Verification Study of JNS020QD in Patients With Osteoarthritis or Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Fentanyl (Primary)
- Indications Back pain; Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 06 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2010 Actual patient number changed from 148 to 151 as reported by ClinicalTrials.gov.
- 02 Dec 2009 Patient numbers amended from 135 to 148 as reported by ClinicalTrials.gov.